摘要
OBJECTIVE: To evaluate the medium- to long-term efficacy of ligustrazine plus conventional medicine treating ischemic stroke. <br>METHODS: Randomized controlled trials (RCTs) testing ligustrazine in the treatment of acute ischemic stroke were retrieved from Cochrane Library, PubMed, Excerpta Medica Database, Chinese Medical Journal Database, Chinese Biomedical Database, China National Knowledge Infrastructure Database, and Chinese Clinical Trial Register, and then identified by the inclusive and exclusive criteria. The quality of trials was assessed with the Cochrane Handbook 5.1, a risk of bias assessment tool. RevMan 5.1 was used for meta-analysis. <br>RESULTS: Three RCTs involving 643 patients were included. Compared to conventional medicine treatment alone, ligustrazine plus conventional medicine treatment showed significant difference in reduction of stroke recurrence either at the end of 1-year follow-up [RR=0.42, 95% CI (0.18, 0.94), P<0.05] or 3-years observation [RR=0.48, 95% CI (0.27, 0.83), P<0.05]. The ligustrazine group also showed higher survival rate [RR=1.67, 95% CI (1.02, 0.2.71), P<0.05] and significantly better effective rate [RR=1.28, 95% CI (1.10, 1.50), P<0.05] than that of the control group at the end of 1 year visit. Only one trial conducted safety assessment and no adverse events were reported. The methodological quality of all the trials included was generally poor. <br>CONCLUSION: The findings provided evidence that the combination of ligustrazine and conventional medication was medium- and long-term beneficial to the patients suffering ischernic stroke. But more RCTs of high quality are needed to further prove the efficacy and safety of using ligustrazine for ischemic stroke.
学科与关键词
- Efficacy and safety of a sequential treatment with clearing heat and eliminating phlegm and tonifying Qi and activating blood circulation in treating acute ischemic stroke: study protocol for a randomized controlled trialZhou Ziyi; Wan Can; Zhao Yuanqi; Liu Xiangzhe; Gao Ying; An Hongwei; Li Lejun; Zhang Huili; Yu Xiaofei; Zhang Xinchun; Wang Huijuan; Shi Qing; Wei Chunhua; Chen Jie; Huang Wenguo; Chen Junbin; Ying, Gao; Hu Mingzhe*; Cai Yefeng*Journal of Traditional Chinese Medicine, 2022, 42(4): 604-610.
- Refined Qing Kai Ling, Traditional Chinese Medicinal Preparation, Reduces Ischemic Stroke-Induced Infarct Size and Neurological Deficits and Increases Expression of Endothelial Nitric Oxide SynthaseQian, Hua; Xiaolei, Zhu; Pengtao, Li; Huiling, Tang; Dayong, Cai; Ya, Xu; Xu, Jia; Jie, Chen; Yong, ShenBiological and Pharmaceutical Bulletin, 2008, 31(4): 633-637.被引 23
- Research progress of natural products for the treatment of ischemic strokeLi, Jiaxin; Zhao, Tingting; Qiao, Hanzi; Li, Yanling; Xia, Mengyao; Wang, Xiaoyu; Liu, Chuanguo; Zheng, Tingting; Chen, Renjie; Xie, Yicheng; Wu, Jibiao; Wei, Xia; Li, Jun; Feng, Yu*; Sun, Peng*Journal of Integrative Neuroscience, 2022, 21(1).被引 17
